Insurance may cover GLP-1 medications for people diagnosed with obesity, which is usually defined as a body mass index (BMI) of 30 or higher
10 mg Other Ingredients for Small Capsule: Hypromellose, Silicon Dioxide
Kidney & Liver Love: Emerging evidence suggests potential benefits for kidney health and the reduction of fatty liver disease, opening up exciting new avenues of research
De Boer IH, Khunti K, Sadusky T, et al
Reduced-frequency GLP-1 as a maintenance strategy: in this case series, patients who tapered from weekly semaglutide/tirzepatide to less frequent dosing maintained weight loss, body composition, and metabolic syndrome gains, supporting structured de-escalation to lower burden without sacrificing efficacy